Global Renal Artery Stenosis Treatment Market, By Drug Type (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Diuretic, Beta-blockers, Angiotensin II Receptor Blockers, Blood Thinners, Angiotensin Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, HMG-CoA Reductase Inhibitors), Treatment (Medication, Renal Artery Endarterectomy, Bypass Surgery, Angioplasty, Others), Diagnosis (CT scan, Magnetic resonance angiography (MRA), Doppler Ultrasound, Renal Arteriography, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Indication (Fibromuscular Dysplasia, Atherosclerosis), Symptoms (Hypertension, Edema, Fluid Retention, Fatigue, Nausea, Vomiting, Decreased kidney functions, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Renal Artery Stenosis Treatment Market
Renal artery stenosis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.60% in the above mentioned forecast period.
Renal artery stenosis (RAS) is a vascular disease in which the arteries' diameter decreases and results in the reduced blood supply to the kidneys. The symptoms of this condition are hypertension, edema, fluid retention, fatigue, nausea, vomiting, decreased kidney functions and increased amount of protein in urine. It is mainly caused due to atherosclerosis.
Rise in the prevalence of renal artery stenosis and growing incidences of atherosclerosis, high blood pressure, diabetes and high cholesterol level are the major factors influencing the market growth rate. Furthermore, rising geriatric population, high consumption of smoking tobacco, increasing healthcare infrastructure, lack of physical exercise, surge in the diagnostic rate due to screening programs and favourable medicare policies are the factors that will expand the renal artery stenosis treatment market.
Rise in the research and development activities and emerging new markets will provide beneficial opportunities for the renal artery stenosis treatment market in the forecast period of 2021-2028.
However, high cost of treatment, side effects associated with the medication are the factors that will hinder the market growth. The lack of awareness about the preventive measures will challenge the renal artery stenosis treatment market in the forecast period mentioned above.
This renal artery stenosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the renal artery stenosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Renal Artery Stenosis Treatment Market Scope and Market Size
The renal artery stenosis treatment market is segmented on the basis of drug type, treatment, diagnosis, dosage, route of administration, indication, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug type, the renal artery stenosis treatment market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), diuretic, beta-blockers, angiotensin II receptor blockers, blood thinners, angiotensin converting enzyme (ACE) inhibitors, calcium channel blockers and HMG-CoA reductase inhibitors
- On the basis of treatment, the renal artery stenosis treatment market is segmented into medication, renal artery endarterectomy, bypass surgery, angioplasty and others.
- On the basis of diagnosis, the renal artery stenosis treatment market is segmented into CT scan, magnetic resonance angiography (MRA), doppler ultrasound, renal arteriography and others.
- On the basis of dosage, the renal artery stenosis treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the renal artery stenosis treatment market is segmented into oral, intravenous and others.
- On the basis of indication, the renal artery stenosis treatment market is segmented into fibromuscular dysplasia and atherosclerosis.
- On the basis of symptoms, the renal artery stenosis treatment market is segmented into hypertension, edema, fluid retention, fatigue, nausea, vomiting, decreased kidney functions and others.
- On the basis of end-users, the renal artery stenosis treatment market is segmented into clinic, hospital and others.
The renal artery stenosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Renal Artery Stenosis Treatment Market Country Level Analysis
Renal artery stenosis treatment market is analyzed and market size information is provided by the country, drug type, treatment, diagnosis, dosage, route of administration, indication, symptoms, end-users and distribution channel as referenced above.
The countries covered in the renal artery stenosis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the renal artery stenosis treatment market due to the presence of major key players, high prevalence of atherosclerosis among elder people and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing healthcare expenditure, rising investment in the healthcare infrastructure and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Renal artery stenosis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Renal Artery Stenosis Treatment Market Share Analysis
Renal artery stenosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to renal artery stenosis treatment market research.
The major players covered in the renal artery stenosis treatment market report are Merck Sharp & Dohme Corp., Pfizer Inc., Sanofi, Novartis AG, Bayer AG, AstraZeneca, Johnson & Johnson Private Limited, Abbott, Eli Lilly and Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Cambrex Corporation, Boehringer Ingelheim International GmbH., Aurobindo Pharma, Mylan N.V., Dr. Reddy’s Laboratories Ltd., BASF SE, Lonza, Sun Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., and Akorn, Incorporated among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-